Table 2.
Predicted functional effects of selected novel splice forms
| Gene symbol | Gene title | Effect of novel splice | Domain affected |
|---|---|---|---|
| CAPNS1 | Calpain small subunit 1/CAPN4 | Deletion of 112 amino acids from N-terminus | Removal of the N-terminal glycine-rich domain (domain V) implicated in interaction with lipids |
| GOSR2 | Golgi SNAP receptor complex member 2 | Deletion of 47 amino acids | Removes part of the potential cytoplasmic domain |
| HLA-DMB | MHC II DM beta | Removes 39 amino acids | Removes the transmembrane domain |
| ITGAE | Integrin, alpha E (antigen CD103) | Deletion of 32 amino acids | Removes part of the integrin alpha E heavy chain domain |
| GOLGA2 | Golgi matrix protein GM130 | Insertion of 27 amino acids | Disrupts the p115 binding site |
| LEF1 | Lymphoid enhancer-binding factor 1, TCF1-alpha | Deletion of 28 amino acids | Removes part of the proline rich domain |
| NFKBIB/IKBβ | I-kappa-B-beta | N-terminus truncated | Removal of two phosphorylation sites and an ankyrin domain |
| NOS2A | Nitric oxide synthase 2A | Deletion of 65 amino acids | Truncation of C-terminus, removing 2 NAD-binding domains |
| PCBP2 | Heterogeneous nuclear ribonucleoprotein E2/poly(rC) binding protein 2 | Deletion of 45 amino acids | Removes the region between KH2 and KH3 domains |
| PDHA | Pyruvate dehydrogenase complex, E1-alpha polypeptide 1 precursor | Insertion of 38 amino acids | Disrupts the region responsible for mitochondrial import of precursor protein |
| TIE1 | Tyrosine kinase with immunoglobulin and EGF factor homology domains | Deletion of 43 amino acids | Removes EGF-like domain 3 |
| WBP2 | WW domain-binding protein 2 | Deletion of 45 amino acids | Removes part of a proline rich domain |